Skip to main content

Corient Private Wealth LLC

Position in NVS — Novartis AG

CIK 1948780 MIAMI, FL

Position in NVS

as of Jun 30, 2026 · filed Aug 17, 2026
Position Value
$70,167,618
+$2,877,272 QoQ
Shares Held
447,726
+1.6% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#45
of 1,603 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 28% Shared 2% None 70%

Common Shares in NVS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Corient Private Wealth LLC holds $2,818,388,817 across 16 Drug Manufacturers - General names. NVS ranks #7 (2.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 NVS
Novartis AG
This page
447,726 $70,167,618

All Filings in NVS

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $70,167,618 447,726
2026-03-31 $67,290,346 440,526
2025-12-31 $66,164,364 479,904
2025-09-30 $58,803,168 458,540
2025-06-30 $54,796,109 452,823
2025-03-31 $51,624,157 463,080
2024-12-31 $52,696,088 541,528
2024-09-30 $66,687,675 579,792
2024-06-30 $61,824,834 580,733
2024-03-31 $56,663,273 585,788
2023-12-31 $59,326,235 587,563
2023-09-30 $46,650,351 457,985
2023-06-30 $45,848,559 454,351
2023-03-31 $37,115,652 403,431
2022-12-31 $23,304,697 256,886